Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid.
Recent studies have shown that rats and mice maintained on a dietary restriction (DR) regimen exhibit increased resistance of neurons to excitotoxic, oxidative, and metabolic insults in experimental models of Alzheimer's, Parkinson's, and Huntington's diseases and stroke. Because synaptic terminals are sites where the neurodegenerative process may begin in such neurodegenerative disorders, we determined the effects of DR on synaptic homeostasis and vulnerability to oxidative and metabolic insults. Basal levels of glucose uptake were similar in cerebral cortical synaptosomes from rats maintained on DR for 3 months compared with synaptosomes from rats fed ad libitum. Exposure of synaptosomes to oxidative insults (amyloid beta-peptide and Fe(2+)) and a metabolic insult (the mitochondrial toxin 3-nitropropionic acid) resulted in decreased levels of glucose uptake. Impairment of glucose uptake following oxidative and metabolic insults was significantly attenuated in synaptosomes from rats maintained on DR. DR was also effective in protecting synaptosomes against oxidative and metabolic impairment of glutamate uptake. Loss of mitochondrial function caused by oxidative and metabolic insults, as indicated by increased levels of reactive oxygen species and decreased transmembrane potential, was significantly attenuated in synaptosomes from rats maintained on DR. Levels of the stress proteins HSP-70 and GRP-78 were increased in synaptosomes from DR rats, consistent with previous data suggesting that the neuroprotective mechanism of DR involves a "preconditioning" effect. Collectively, our data provide the first evidence that DR can alter synaptic homeostasis in a manner that enhances the ability of synapses to withstand adversity.
Guo
Z
Z
Sanders-Brown Research Center on Aging. Department of Chemistry and Center of Membrane Sciences, University of Kentucky, Lexington, Kentucky, USA.
Ersoz
A
A
Butterfield
D A
DA
Mattson
M P
MP
D016229:Amyloid beta-Peptides / Q000494:pharmacology*; D000818:Animals; D001692:Biological Transport; D002540:Cerebral Cortex / Q000648:ultrastructure*; D005508:Food Deprivation; D005947:Glucose / Q000378:metabolism; D018698:Glutamic Acid / Q000378:metabolism; D006360:Heat-Shock Proteins / Q000378:metabolism; D007501:Iron / Q000494:pharmacology*; D008297:Male; D008928:Mitochondria / Q000502:physiology*; D009574:Nitro Compounds; D018384:Oxidative Stress; D017729:Presynaptic Terminals / Q000187:drug effects / Q000502:physiology*; D011422:Propionates / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D016229:Amyloid beta-Peptides; D006360:Heat-Shock Proteins; D009574:Nitro Compounds; D011422:Propionates; D018698:Glutamic Acid; D007501:Iron; D005947:Glucose; C015392:3-nitropropionic acid